National Consumers League

From the Experts Blog

NCL staff is hard at work for you playing watchdog on a variety of issues. Get to know the latest From the Experts!

Happy 5th Anniversary to the CFPB

hrudder.jpgSince its inception five years ago, the Consumer Financial Protection Bureau (CFPB) has worked tirelessly to protect consumers from deceptive and abusive financial practices through its implementation of rules, programs, and new protective financial tools. For the past three years, under the direction of Richard Cordray, former Attorney General of Ohio, the CFPB has handled over 900,000 consumer complaints with 97 percent of those complaints receiving timely replies.  Over 25 million consumers will receive over $11.4 billion in relief from CFPB enforcements.  

Read More →

Reflections on the RNC and DNC

Last week I attended the Democratic National Convention in Philadelphia. What a contrast with the Republican convention in Cleveland, which I also attended, the previous week. The RNC was overwhelmingly white (there were approximately 18 black delegates at the Republican National Convention.

Read More →

Day two from the RNC

SG_HEADSHOT.jpgThe buzz at the breakfast event on St. Clair today was all about the plagiarized sections of Melania Trump’s speech and how in the world that could have happened. At my morning event sponsored by The Atlantic Magazine, I sat next to a theater professor from a Maryland college who is spending her sabbatical studying the theatricality of the campaign. She regularly vets student papers for plagiarism through commonly used websites. Oops-guess the Trump campaign forgot to undertake that simple task.

Read More →

Day one from the RNC

Here I am in Cleveland, the host city of the Republican National Convention. I ended my day at the Rock and Roll Hall of Fame, a must-see American museum icon with gorgeous views of this beautiful city on Lake Erie. Cleveland is an unlikely host city for the RNC; it remains a stronghold of democratic activism:

Read More →

Believing women patients

SG-headshot.jpgLast year, the FDA approved a drug for female low libido–known as Hypoactive Sexual Desire Disorder or HSDD–for the first time in history. It didn’t happen without a great deal of naysaying by the media, pharmaceutical company critics and most disappointing, some feminists. The skeptics questioned whether the millions of women who complained of having lost their sex drive were imagining the condition.

Read More →